reported a robust set of numbers for the September quarter, with consolidated net profit soaring 82% year-on-year to ₹322 crore, compared to ₹176.5 crore in the same period last year. Revenue grew 17.3% to ₹2,331.4 crore, supported by sustained growth across its hospital and diagnostics businesses. Operating performance remained healthy, with EBITDA rising 28% year-on-year to ₹557 crore, while margins expanded to 24% from 22% a year ago, reflecting improved cost management and higher occupancy levels across key facilities.

#WatchOutFor#StockInNews#TechnicalViews#FundamentalViews#Miscellaneous

1,117 likes·53 comments